Na JI - Search Results

1

Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis.

Kim DS, Kim SY, Park SH, Choi YG, Kwon SB, Kim MK, Na JI, Youn SW, Park KC. Kim DS, et al. Among authors: na ji. Biol Pharm Bull. 2005 Dec;28(12):2216-9. doi: 10.1248/bpb.28.2216. Biol Pharm Bull. 2005. PMID: 16327152 Free article.

2

Differential regulation of melanosomal proteins after hinokitiol treatment.

Choi YG, Bae EJ, Kim DS, Park SH, Kwon SB, Na JI, Park KC. Choi YG, et al. Among authors: na ji. J Dermatol Sci. 2006 Sep;43(3):181-8. doi: 10.1016/j.jdermsci.2006.05.003. Epub 2006 Jun 15. J Dermatol Sci. 2006. PMID: 16781122

3

Light-activated indole-3-acetic acid induces apoptosis in g361 human melanoma cells.

Kim DS, Kim SY, Jeong YM, Jeon SE, Kim MK, Kwon SB, Na JI, Park KC. Kim DS, et al. Among authors: na ji. Biol Pharm Bull. 2006 Dec;29(12):2404-9. doi: 10.1248/bpb.29.2404. Biol Pharm Bull. 2006. PMID: 17142972 Free article.

4

Effects of mesenchymal stem cells in the reconstruction of skin equivalents.

Huh CH, Kim SY, Cho HJ, Kim DS, Lee WH, Kwon SB, Na JI, Park KC. Huh CH, et al. Among authors: na ji. J Dermatol Sci. 2007 Jun;46(3):217-20. doi: 10.1016/j.jdermsci.2007.01.005. Epub 2007 Feb 20. J Dermatol Sci. 2007. PMID: 17317109 No abstract available.

5

Glutathione prevented dopamine-induced apoptosis of melanocytes and its signaling.

Park ES, Kim SY, Na JI, Ryu HS, Youn SW, Kim DS, Yun HY, Park KC. Park ES, et al. Among authors: na ji. J Dermatol Sci. 2007 Aug;47(2):141-9. doi: 10.1016/j.jdermsci.2007.03.009. Epub 2007 May 4. J Dermatol Sci. 2007. PMID: 17481858

6

Additive effects of heat and p38 MAPK inhibitor treatment on melanin synthesis.

Kim DS, Park SH, Kwon SB, Na JI, Huh CH, Park KC. Kim DS, et al. Among authors: na ji. Arch Pharm Res. 2007 May;30(5):581-6. doi: 10.1007/BF02977652. Arch Pharm Res. 2007. PMID: 17615677

7

Angioblastoma showing aggravation after treatment with long-pulsed Nd:YAG laser (1064 nm).

Na JI, Cho KH, Kim YG, Park KC. Na JI, et al. Pediatr Dermatol. 2007 Jul-Aug;24(4):397-400. doi: 10.1111/j.1525-1470.2007.00495.x. Pediatr Dermatol. 2007. PMID: 17845165

8

Terrein inhibits keratinocyte proliferation via ERK inactivation and G2/M cell cycle arrest.

Kim DS, Lee HK, Park SH, Lee S, Ryoo IJ, Kim WG, Yoo ID, Na JI, Kwon SB, Park KC. Kim DS, et al. Among authors: na ji. Exp Dermatol. 2008 Apr;17(4):312-7. doi: 10.1111/j.1600-0625.2007.00646.x. Epub 2007 Nov 2. Exp Dermatol. 2008. PMID: 17979972

9

C-terminal peptide of IGFBP-3, KGRKR, prolongs the proliferative potential of basal keratinocytes.

Cho HJ, Lee HK, Na JI, Shin JW, Youn SW, Park KC, Kim DS. Cho HJ, et al. Among authors: na ji. J Dermatol Sci. 2008 Apr;50(1):61-4. doi: 10.1016/j.jdermsci.2007.10.005. Epub 2007 Nov 28. J Dermatol Sci. 2008. PMID: 18053690 No abstract available.

10

The hypopigmentary action of KI-063 (a new tyrosinase inhibitor) combined with terrein.

Kim DS, Lee S, Lee HK, Park SH, Ryoo IJ, Yoo ID, Kwon SB, Baek KJ, Na JI, Park KC. Kim DS, et al. Among authors: na ji. J Pharm Pharmacol. 2008 Mar;60(3):343-8. doi: 10.1211/jpp.60.3.0009. J Pharm Pharmacol. 2008. PMID: 18284814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

447 results

Search Page

Filters